.png)
.png)
MD
Massachusetts General Hospital
Disclosure(s): No financial relationships to disclose
Kimberly Blumenthal, MD, MSc is an Allergist/Immunologist and clinical researcher at Massachusetts General Hospital and Assistant Professor of Medicine at Harvard Medical School. She is the Co-Director of the Clinical Epidemiology Program within the Division of Rheumatology Allergy and Immunology and the Quality and Safety Officer for Allergy at the Edward P. Lawrence Center for Quality and Safety. Dr. Blumenthal performs drug and vaccine allergy research that uses methods of epidemiology, informatics, economics, and decision science. Her research has been funded by the National Institute of Health, Agency for Healthcare Research and Quality, and foundations, including the American Academy of Allergy, Asthma, and Immunology Foundation and CRICO, the risk management foundation of Harvard Medical School. Dr. Blumenthal is recognized for identifying the morbidity and mortality associated with unverified penicillin allergy and creating innovative approaches to the evaluation of penicillin and cephalosporin antibiotic allergies in diverse patient settings. Dr. Blumenthal has authored more than 100 peer-reviewed publications including manuscripts published in high-impact journals such as NEJM, Lancet, JAMA, and the BMJ.
Dr. Blumenthal graduated from Columbia University with a BA in Economics. She studied medicine at Yale University School of Medicine, before training at the Massachusetts General Hospital for Internal Medicine and Allergy and Immunology. She completed a Master of Science in Clinical Epidemiology at the Harvard T.H. Chan School of Public Health in 2017.